Literature DB >> 15947944

Portal capillary C4d deposits and increased infiltration by macrophages indicate humorally mediated mechanisms in acute cellular liver allograft rejection.

Anja Dankof1, Maximilian Schmeding, Lars Morawietz, Raphaela Günther, Manfred G Krukemeyer, Birgit Rudolph, Martin Koch, Veit Krenn, Ulf Neumann.   

Abstract

Almost no data exist concerning the role of antibody-mediated mechanisms in human acute cellular liver allograft rejection (ACR). Therefore, the aim of this study was to determine whether ACR is associated with depositions of complement split products and increased infiltration by B-lymphocytes, plasma cells and macrophages. A total of 35 liver biopsy specimens (ACR n=22, controls n=13) were analyzed by immunohistochemical single and double staining. The average numbers of CD 20(+), CD 38(+) and CD 68(+) cells per portal tract were established while the presence of C4d and C3d deposits was evaluated semiquantitatively. Significantly greater numbers of CD 20(+) (P=0.029) and CD 38(+) (P=0.014) cells were found in the ACR specimens than in the control specimens. Additionally, 50% of patients diagnosed with ACR showed C4d deposits along portal capillaries, which was associated with a significantly increased portal infiltration by macrophages (P=0.007). Taken together these results support the involvement of humorally mediated mechanisms in some cases of ACR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15947944     DOI: 10.1007/s00428-005-1245-z

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  20 in total

1.  Cellular and humoral mechanisms of vascularized allograft rejection induced by indirect recognition of donor MHC allopeptides.

Authors:  J P Vella; C Magee; L Vos; K Womer; H Rennke; C B Carpenter; W Hancock; M H Sayegh
Journal:  Transplantation       Date:  1999-06-27       Impact factor: 4.939

2.  Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages.

Authors:  P C Grimm; R McKenna; P Nickerson; M E Russell; J Gough; E Gospodarek; B Liu; J Jeffery; D N Rush
Journal:  J Am Soc Nephrol       Date:  1999-07       Impact factor: 10.121

3.  Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection.

Authors:  Alex B Magil; Kathryn Tinckam
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

Review 4.  Role of the complement system in rejection.

Authors:  Steven H Sacks; Paramit Chowdhury; Wuding Zhou
Journal:  Curr Opin Immunol       Date:  2003-10       Impact factor: 7.486

5.  Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection.

Authors:  H E Feucht; E Felber; M J Gokel; G Hillebrand; U Nattermann; C Brockmeyer; E Held; G Riethmüller; W Land; E Albert
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

6.  C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease.

Authors:  Nelli Shushakova; Julia Skokowa; Jurriaan Schulman; Ulrich Baumann; Jörg Zwirner; Reinhold E Schmidt; J Engelbert Gessner
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

7.  Postoperative flow cytometry crossmatch in living donor liver transplantation: clinical significance of humoral immunity in acute rejection.

Authors:  M Kasahara; T Kiuchi; K Takakura; K Uryuhara; H Egawa; K Asonuma; S Uemoto; Y Inomata; S Ohwada; Y Morishita; K Tanaka
Journal:  Transplantation       Date:  1999-02-27       Impact factor: 4.939

8.  Macrophages and chronic renal allograft nephropathy.

Authors:  B P Croker; W L Clapp; A R Abu Shamat; B C Kone; J C Peterson
Journal:  Kidney Int Suppl       Date:  1996-12       Impact factor: 10.545

9.  Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease.

Authors:  Paul J Michaels; Maria L Espejo; Jon Kobashigawa; Juan C Alejos; Caron Burch; Steve Takemoto; Elaine F Reed; Michael C Fishbein
Journal:  J Heart Lung Transplant       Date:  2003-01       Impact factor: 10.247

10.  Immunoglobulin G lymphocytotoxic antibodies in clinical liver transplantation: studies toward further defining their significance.

Authors:  R Mañez; R H Kelly; M Kobayashi; S Takaya; O Bronsther; D Kramer; R J Duquesnoy; Y Iwaki; J J Fung; T E Starzl
Journal:  Hepatology       Date:  1995-05       Impact factor: 17.425

View more
  7 in total

1.  Critical Role of Macrophage FcγR Signaling and Reactive Oxygen Species in Alloantibody-Mediated Hepatocyte Rejection.

Authors:  Jason M Zimmerer; Xin L Liu; Alecia Blaszczak; Christina L Avila; Thomas A Pham; Robert T Warren; Ginny L Bumgardner
Journal:  J Immunol       Date:  2018-11-05       Impact factor: 5.422

2.  Critical role of effector macrophages in mediating CD4-dependent alloimmune injury of transplanted liver parenchymal cells.

Authors:  Phillip H Horne; Jason M Zimmerer; Mason G Fisher; Keri E Lunsford; Gyongyi Nadasdy; Tibor Nadasdy; Nico van Rooijen; Ginny L Bumgardner
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

3.  Positive C4d staining of the portal vein endothelium in the liver of patients with biliary atresia: a role of humoral immunity in ongoing liver fibrosis.

Authors:  Sorahiko Fujisawa; Toshihiro Muraji; Naoya Sakamoto; Naoki Hosaka; Satoshi Matsuda; Hajime Kawakami; Misako Hirai; Toshihiro Yanai
Journal:  Pediatr Surg Int       Date:  2014-07-27       Impact factor: 1.827

4.  The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.

Authors:  A I Musat; R M Agni; P Y Wai; J D Pirsch; D F Lorentzen; A Powell; G E Leverson; J M Bellingham; L A Fernandez; D P Foley; J D Mezrich; A M D'Alessandro; M R Lucey
Journal:  Am J Transplant       Date:  2011-03       Impact factor: 8.086

5.  Quantification of C4d deposition and hepatitis C virus RNA in tissue in cases of graft rejection and hepatitis C recurrence after liver transplantation.

Authors:  Alice Tung Wan Song; Evandro Sobroza de Mello; Venâncio Avancini Ferreira Alves; Norma de Paula Cavalheiro; Carlos Eduardo Melo; Patricia Rodrigues Bonazzi; Fatima Mitiko Tengan; Maristela Pinheiro Freire; Antonio Alci Barone; Luiz Augusto Carneiro D'Albuquerque; Edson Abdala
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-02-13       Impact factor: 2.743

Review 6.  ABO-compatible liver allograft antibody-mediated rejection: an update.

Authors:  Anthony J Demetris; Adriana Zeevi; Jacqueline G O'Leary
Journal:  Curr Opin Organ Transplant       Date:  2015-06       Impact factor: 2.640

7.  Acute Antibody-mediated Rejection Coexisting With T Cell-mediated Rejection in Pediatric ABO-incompatible Transplantation.

Authors:  Yusuke Yanagi; Seisuke Sakamoto; Masaki Yamada; Koutaro Mimori; Toshimasa Nakao; Tasuku Kodama; Hajime Uchida; Seiichi Shimizu; Akinari Fukuda; Noriyuki Nakano; Chiduko Haga; Takako Yoshioka; Mureo Kasahara
Journal:  Transplant Direct       Date:  2022-08-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.